Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Morinaga Milk develops peptides with antifungal activity

July 22, 1998

Erythromycins from Taisho for Gram-positive infections

July 22, 1998

RiboGene receives additional funding in the area of antifungals

July 21, 1998

Antifungal series emerges from R&D at Pola

July 21, 1998

Potent, broad-spectrum antibacterial compounds developed at Daiichi

July 21, 1998

NeXstar initiates third phase II MiKasome trial

July 21, 1998

Sankyo presents new antifungal agents for Candida infections

July 20, 1998

Antibacterial agent of microbial origin discovered by Sankyo

July 20, 1998

Pola discloses new antifungal agents

July 17, 1998

Locally applied fusafungine for rhinitis and sinusitis

July 17, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...